Comprehensive Study Notes on Inflammation: Acute, Chronic, and Systemic Responses

Introduction to Inflammation

  • Definition: Inflammation is a response (reaction) of living vascularized tissues to endogenous and exogenous stimuli that cause cell injury.
  • Nature of the Response:
    • It is fundamentally a protective response.
    • It may be harmful in some situations (e.g., hypersensitivity).
    • It is closely intertwined with the process of tissue repair and the healing process.
  • Purpose: It serves to rid the body of both the initial cause of cell injury (e.g., microbes, toxins) and the consequences of such injury (e.g., necrotic cells and tissues).
  • Consequences of Absence: Without inflammation, infections would go unchecked, wounds would never heal, and injured tissues might remain permanent.
  • Harms of Inflammation: The reaction can become the cause of disease when excessive or inappropriate:
    • Autoimmune diseases.
    • Hypersensitivity reactions.
    • Systemic Inflammatory Response Syndrome (SIRS).
    • Defective Inflammation: This is also responsible for serious illness.

Comparison of Acute and Chronic Inflammation

  • Classification Criteria: Inflammation is classified based on the duration of the lesion and histologic appearances.
  • Acute Inflammation:
    • Duration: Relatively short (hours to days).
    • Characteristics: Exudation of fluid and plasma proteins; predominantly neutrophilic (PMN) infiltration.
    • Onset: Fast (minutes or hours).
    • Tissue Injury: Usually mild and self-limited.
    • Local/Systemic Signs: Prominent.
  • Chronic Inflammation:
    • Duration: Longer (days to years).
    • Characteristics: Infiltration with mononuclear cells (macrophages, lymphocytes, plasma cells), vascular proliferation (angiogenesis), and scarring (fibrosis).
    • Onset: Slow (days).
    • Tissue Injury: May be severe and progressive.
    • Local/Systemic Signs: Less prominent.

Sequential Steps of the Inflammatory Reaction

  1. Recognition: Identifying the noxious agent or initiating stimulus.
  2. Recruitment: Bringing leukocytes and plasma proteins from the blood into the tissues.
  3. Removal: Eliminating the stimulus for inflammation.
  4. Regulation: Controlling the response to prevent excessive damage.
  5. Repair: A series of events that heal the damaged tissue.

Recognition of Microbes and Damaged Cells

  • Cellular Receptors for Microbes:
    • Toll-like Receptors (TLRs): Located in plasma membranes and endosomes. They recognize Pathogen-Associated Molecular Patterns (PAMPs).
    • Function: Stimulates the production and expression of secreted and membrane proteins.
  • Sensors of Cell Damage:
    • Cytosolic receptors recognize Damage-Associated Molecular Patterns (DAMPs).
    • DAMP Examples: Uric acid, ATP, reduced intracellular K+K^+ concentrations, and extranuclear DNA.
    • Inflammasome: A multiprotein cytosolic complex activated by receptors. It induces the production of the cytokine Interleukin-1 (IL-1).
    • Autoinflammatory Syndromes: Caused by gain-of-function mutations in these cytosolic receptors.
  • Circulating Proteins:
    • Mannose-binding Lectin: Recognizes microbial sugars; promotes ingestion (opsonization) and activates the complement system.
    • Collectins: Bind to microbes and promote phagocytosis.

Acute Inflammation: Causes and Major Components

  • Causes:
    • Infections (bacterial, viral, fungal, parasitic).
    • Trauma (physical and chemical agents).
    • Tissue necrosis (e.g., from ischemia).
    • Foreign bodies (e.g., splinters, sutures).
    • Immune reactions (hypersensitivity).
  • Major Components:
    1. Vasodilation.
    2. Increased vascular permeability.
    3. Emigration of leukocytes from microcirculation and their activation.

Terminology and Fluid Dynamics

  • Edema: Excess fluid in interstitial or serous cavities; can be exudate or transudate.
  • Exudation: The escape of fluid, proteins, and blood cells from the vascular system into interstitial tissue.
  • Exudate:
    • Inflammatory extravascular fluid.
    • High protein concentration and cellular debris.
    • Specific gravity above 1.0201.020.
    • Implies an alteration in normal permeability of small blood vessels.
  • Pus (Purulent Exudate): An inflammatory exudate rich in leukocytes (mostly neutrophils), debris, and microbes.
  • Transudate:
    • Low protein content and few cells.
    • Specific gravity less than 1.0201.020.
    • Results from osmotic or hydrostatic imbalance (e.g., heart failure, liver disease) without increased vascular permeability.

Vascular Response and Leakiness Mechanisms

  • Vascular Events:
    1. Brief arteriolar vasoconstriction.
    2. Vasodilation (induced by histamine, nitric oxide, bradykinin): Accounts for warmth (calor) and redness (rubor).
    3. Stasis: Slower blood flow as dilated vessels become packed with red cells.
  • Mechanisms of Vascular Permeability:
    1. Endothelial Cell Contraction: Most common. Widens intercellular gaps in venules. Induced by histamine, bradykinins, leukotrienes (Immediate transient response: 1530min15 \text{--} 30\,\text{min}). Cytokines (TNF, IL-1) cause junction retraction (46hrs4 \text{--} 6\,\text{hrs} post-injury, lasting over 24hrs24\,\text{hrs}).
    2. Direct Endothelial Injury: Caused by severe injuries (burns, toxins).Leads to necrosis and detachment. Immediate sustained response (affects all microcirculation levels) or delayed prolonged leakage (212hrs2 \text{--} 12\,\text{hrs} later).
    3. Leukocyte-Mediated Injury: Adherent leukocytes release toxic oxygen radicals and proteolytic enzymes, damaging endothelium.
    4. Increased Transcytosis: Mediated by VEGF via intracellular vesicles.
    5. Angiogenesis: Leakage from new, immature blood vessels.

Cellular Response: Leukocyte Extravasation

  • Extravasation Sequence:
    1. Margination: Accumulation of neutrophils along endothelial surfaces (peripheral zone) due to hemodynamic changes.
    2. Rolling: Leukocytes tumble and adhere transiently. Mediated by the Selectin family:
      • L-selectin: On most leukocytes.
      • E-selectin: On endothelial cells.
      • P-selectin: On endothelium and platelets.
      • Selectins bind sialylated oligosaccharides (e.g., Sialyl-Lewis X).
    3. Adhesion: Firm binding to endothelium. Regulated by:
      • Integrins: On leukocytes (VLA-4, LFA-1).
      • Immunoglobulin Superfamily: On endothelial cells (ICAM-1, VCAM-1).
    4. Transmigration (Diapedesis): Squeezing between endothelial cells at junctions. Mediated by PECAM-1 (CD31). Leukocytes use collagenases to cross the basement membrane.
    5. Chemotaxis: Unidirectional migration toward a chemical gradient. Important factors:
      • Exogenous: Bacterial products.
      • Endogenous: Complement C5aC5a, Leukotriene B4B_4 (LTB4LTB_4), and Cytokines (e.g., IL-8IL\text{-}8).

Phagocytosis and Killing

  • Leukocyte Activation: Triggered by microbes and necrotic products; results in increased cytosolic Ca2+Ca^{2+} and activation of enzymes (PKC, Phospholipase A2A_2).
  • Phagocytosis Steps:
    1. Recognition and Attachment: Facilitated by Opsonins (IgG Fc portion, C3bC3b, collectins). Receptors include mannose and scavenger receptors.
    2. Engulfment: Pseudopodia enclose the particle into a phagosome, which fuses with a lysosome to form a phagolysosome.
    3. Killing and Degradation:
      • Reactive Oxygen Species (ROS): NADPH oxidase converts oxygen to superoxide (O2O_2^{\cdot -}), then to hydrogen peroxide (H2O2H_2O_2).
      • Myeloperoxidase (MPO): Converts H2O2H_2O_2 and ClCl^- to HOCl (hypochlorous radical), a potent antimicrobial.
      • Reactive Nitrogen Species: Derived from Nitric Oxide (NO).
  • Granule Constituents:
    • Major Basic Protein: Toxic to parasites (eosinophils).
    • Defensins: Punch holes in membranes.
    • Lysozyme: Degrades bacterial coat sugars.

Defects in Leukocyte Function

  • Leukocyte Adhesion Deficiency (LAD):
    • LAD-1: Lack of integrins; leads to impaired adhesion and phagocytosis.
    • LAD-2: Absence of Sialyl-Lewis X.
  • Chronic Granulomatous Disease (CGD): Inherited defects in NADPH oxidase; leads to recurrent bacterial infections (lungs, nares, gingivitis).
  • Chediak-Higashi Syndrome: Autosomal recessive; disordered intracellular trafficking. Characterized by neutropenia, delayed killing, giant granules, and recurrent infections.
  • Acquired Defects: Can occur in diabetes mellitus, thermal injuries, sepsis, malnutrition, and due to certain drugs.

Chemical Mediators of Inflammation

  • General Characteristics:
    • Produced in response to stimuli (microbes, necrotic cells).
    • Most bind to specific receptors; some have direct enzymatic activity.
    • Short-lived: decay quickly, inactivated enzymatically, or scavenged.
  • Vasoactive Amines:
    • Histamine: Main source is mast cells. Stimulated by trauma, IgE, anaphylatoxins (C3aC3a, C5aC5a), neuropeptides (SubstancePSubstance\,P). Causes arteriolar dilation and increased venular permeability via H1H_1 receptors.
    • Serotonin (5-HT): Found in platelets and enterochromaffin cells. Acts as a neurotransmitter and vasoconstrictor.
  • Arachidonic Acid (AA) Metabolites (Eicosanoids):
    • Release: AA is released from membrane phospholipids by Phospholipase A2A_2.
    • Cyclooxygenase (COX) Pathway: Produces Prostaglandins.
      • COX-1: Constitutively expressed; homeostatic (GIT, kidneys).
      • COX-2: Induced by inflammation.
      • PGE2PGE_2: Fever, pain, vasodilation.
      • PGI2PGI_2 (Prostacyclin): Vasodilation, inhibits platelet aggregation.
      • TXA2TXA_2 (Thromboxane): Vasoconstriction, promotes platelet aggregation.
      • PGD2PGD_2: Vasodilation, edema, neutrophil chemoattractant.
    • Lipoxygenase Pathway: Produces Leukotrienes and Lipoxins.
      • LTB4LTB_4: Chemotactic agent, neutrophil activator.
      • LTC4LTC_4, LTD4LTD_4, LTE4LTE_4: Vasoconstriction, bronchospasm, increased permeability.
      • Lipoxins (LXA4LXA_4, LXB4LXB_4): Suppress inflammation by inhibiting leukocyte recruitment.

Cytokines and Chemokines

  • TNF and IL-1: "Master Cytokines" produced by macrophages and dendritic cells.
    • Local Effects: Endothelial activation (selectin expression), procoagulant activity.
    • Systemic Effects: Fever, metabolic abnormalities, hypotension (shock).
    • TNF specific: Promotes lipid/protein catabolism; contributes to cachexia.
  • IL-6: Systemic acute-phase response.
  • Chemokines: Small proteins classified by cysteine arrangement:
    • C-X-C (e.g., IL-8/CXCL8): Acts mainly on neutrophils.
    • C-C (e.g., MCP-1, Eotaxin): Recruits monocytes, eosinophils, lymphocytes.
    • C: Specific for lymphocytes.
    • CX3C (Fractalkine): Strong adhesion for monocytes/T cells.
    • Function: Inflammatory (recruitment) and Homeostatic (tissue architecture).

Plasma-Derived Mediators

  • Complement System: Defensive enzymatic cascade. Critical step is C3C3 cleavage.
    • Classical Pathway: Triggered by antigen-antibody complex (IgM or IgG).
    • Alternative Pathway: Triggered by microbial surfaces (LPS, polysaccharides).
    • Lectin Pathway: Mannose-binding lectin binds microbial sugars.
    • Products: C3aC3a, C5aC5a (Inflammation, anaphylatoxins); C3bC3b (Opsonization); C5b9C5b\text{--}9 (Membrane Attack Complex/MAC for cell lysis).
    • Regulators: C1inhibitorC1\,inhibitor (deficiency causes hereditary angioedema), DAFDAF and CD59CD59 (deficiency in PNHPNH causes red cell lysis), FactorHFactor\,H.
  • Kinins: Derived from High Molecular Weight Kininogen (HMWK). Bradykinin causes permeability, smooth muscle contraction, vasodilation, and pain.
  • Clotting System: FactorXaFactor\,Xa (permeability), Thrombin (adhesion), Fibrinopeptides (chemotaxis).

Morphologic Patterns of Acute Inflammation

  • Serous Inflammation: Exudation of cell-poor, watery fluid. Accumulation in cavities is an effusion (e.g., skin blister, viral infection).
  • Fibrinous Inflammation: Occurs with large vascular leaks or procoagulant stimuli (cancer). Fibrinogen passes out and forms fibrin. Characteristic of body cavity linings (pericardium). Can lead to organization and scarring.
  • Suppurative (Purulent) Inflammation: Production of pus (neutrophils, debris, edema). Caused by pyogenic bacteria (e.g., staphylococci).
    • Abscess: Circumscribed accumulation of pus within a tissue, often with a central necrotic region and a pyogenic membrane.
  • Ulcers: Local defect/excavation of a surface produced by sloughing of inflamed necrotic tissue. Common in GIT mucosa and skin of lower extremities.
  • Catarrhal: Mild inflammation of mucous membranes (e.g., Rhinitis).
  • Pseudomembranous: Extensive confluent necrosis and fibrinopurulent layer over mucosa (e.g., Diphtheria, C. difficile colitis).

Outcomes of Acute Inflammation

  1. Complete Resolution: Normal structure restored. Happens when injury is short-lived with little destruction.
  2. Healing by Connective Tissue Replacement (Scarring/Fibrosis): Occurs after substantial destruction, in non-regenerative tissues, or with abundant fibrin (Organization).
  3. Progression to Chronic Inflammation: Occurs when the response cannot be resolved due to persistent injury or healing interference.

Chronic Inflammation

  • Definition: Prolonged process (weeks/months) where inflammation, destruction, and repair proceed simultaneously.
  • Causes: Persistent infections (TB, leprosy), prolonged exposure to toxins (silica, asbestos, lipids in atherosclerosis), and autoimmunity.
  • Cells of Chronic Inflammation:
    • Macrophages: Dominant cells. Classically activated (M1) via IFN-γ\gamma/microbes (microbicidal, pro-inflammatory) or Alternatively activated (M2) via IL-4/IL-13 (repair, anti-inflammatory).
    • Lymphocytes: Th1Th1 (IFN-γ\gamma for M1), Th2Th2 (IL-4/5/13 for eosinophils/M2), Th17Th17 (IL-17 for PMNs).
    • Eosinophils: IgE-mediated reactions and parasites. Contain major basic protein.
    • Mast Cells: Release cytokines for both acute and chronic phases.

Granulomatous Inflammation

  • Definition: A form of chronic inflammation characterized by collections of activated macrophages (epithelioid cells) and T lymphocytes.
  • Types:
    • Foreign Body Granuloma: Incited by inert materials (sutures, talc).
    • Immune Granuloma: Caused by persistent microbes (TB) inducing a T-cell response.
  • Morphology:
    • Epithelioid cells: Macrophages with abundant cytoplasm.
    • Langhans Giant Cells: Fused macrophages with peripheral nuclei.
    • Caseating Granuloma: Central cheese-like necrosis due to hypoxia/free radicals (e.g., Tuberculosis).
    • Non-caseating: No central necrosis (e.g., Sarcoidosis, Crohn disease).

Systemic Effects of Inflammation (Acute Phase Response)

  • Mediators: TNF, IL-1, IL-6.
  • Fever: Cytokines stimuate PGE2 production in the hypothalamus to reset the temperature set-point.
  • Leukocytosis: Cytokines stimulate bone marrow production. Levels may reach 40,000100,000cells/μl40,000 \text{--} 100,000\,\text{cells/}\mu\text{l} (Leukemoid reaction). "Shift to the left" refers to immature neutrophils.
  • Acute Phase Proteins (Liver-derived):
    • C-Reactive Protein (CRP): Opsonin, fixes complement. High levels associated with coronary artery disease.
    • Serum Amyloid A (SAA): Can cause secondary amyloidosis in chronic inflammation.
    • Fibrinogen: Causes Red Blood Cells to stack (rouleaux), increasing the Erythrocyte Sedimentation Rate (ESR).
    • Hepcidin: Iron-regulating peptide; chronically high levels cause the anemia of chronic inflammation.
  • Clinical Signs: Increased HR/BP, rigors, chills, anorexia, somnolence, and malaise.
  • Septic Shock: Fall in BP, DIC, and metabolic abnormalities induced by high TNF levels in severe infections.